Insider filing
Traded Nov 17 · filed 2 days later
Gift or transfer — classified separately from trades.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 19, 2026 · Filed Oct 20, 2026
The CEO of Crispr Therapeutics sold $2.38M of Crispr Therapeutics shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$2,381,326
Shares × reported transaction price
77 days after results of Aug 3, 2026, 14 days before results of Nov 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $50.04 on Oct 19, 2026, 13% above its 52-week low and 32% below its high, after a 10% drop over the previous 30 trading days
52-week range $44.34 (Mar 30, 2026) to $73.97 (Oct 20, 2025), 19% of the way up, from 250 adjusted closes. 30 trading days earlier: $55.79 on Sep 4, 2026. Describes the past only, not a forecast
RSI 42, 6% under its 200-day average, 9% under its 50-day average, 32% below the 52-week high, 20-day volatility 51% a year, against the S&P 500: −12 points over 1 month, +3 points over 3 months, −22 points over 6 months
From the adjusted closes up to Oct 19, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Traded 14 days before CRSP reported its results (Nov 2, 2026)
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +7.2% | −0.1% | +7.3% |
| 30 days | −22.6% | −10.8% | −11.8% |
Past results only. Not a forecast.
Insider filing
Traded Nov 17 · filed 2 days later
Gift or transfer — classified separately from trades.
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Insider filing
Traded Nov 4 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.